Renal cell carcinomas mass of <4 cm are not always indolent
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Renal cell carcinomas mass of <4 cm are not always indolent. / Azawi, Nessn H; Lund, Lars; Fode, Mikkel.
In: Urology Annals, Vol. 9, No. 3, 2017, p. 234-238.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Renal cell carcinomas mass of <4 cm are not always indolent
AU - Azawi, Nessn H
AU - Lund, Lars
AU - Fode, Mikkel
PY - 2017
Y1 - 2017
N2 - CONTEXT: The rate of progression to metastatic disease in patients undergoing active surveillance for small renal tumors varies in the literature between 1% and 8%.AIMS: This study aims to examine the incidence of metastasis in small renal tumors of <4 cm in a Danish cohort.SETTINGS AND DESIGN: Retrospective.MATERIALS AND METHODS: Data on 106 patients who were diagnosed with renal cancer (RCC) of <4 cm by CT scan from January 2005 to December 2013 were collected retrospectively in January 2016 from patient charts and analyzed.STATISTICAL ANALYSIS USED: The cancer-specific survival (CSS) and overall survival (OS) were estimated using Kaplan-Meier methods.RESULTS: The mean age was 62 years (range 40-84 years). Two patients (1.9%) had metastases at the time of diagnosis. Radical nephrectomy was performed in 74 patients (70%); of them, one patients (1.4%) experienced late metastasis (LM). Partial nephrectomy was performed in 30 patients (28%); of them, two patients (6.7%) experienced LM. The mean time to LM was 27 ± 12 months (95% confidence interval: 4-56). CSS rates were 98%, 97%, and 97% for 1, 3, and 5 years, respectively, while OS rates were 96%, 92%, and 86% for 1, 3, and 5 years, respectively. On multivariate analysis, tumor size (P = 0.04), pT3a (P = 0.0017), and patient's age (P = 0.02) at the time of diagnosis were significant predictors of LM.CONCLUSIONS: Even small renal carcinomas may be aggressive, and caution should be taken when offering active surveillance.
AB - CONTEXT: The rate of progression to metastatic disease in patients undergoing active surveillance for small renal tumors varies in the literature between 1% and 8%.AIMS: This study aims to examine the incidence of metastasis in small renal tumors of <4 cm in a Danish cohort.SETTINGS AND DESIGN: Retrospective.MATERIALS AND METHODS: Data on 106 patients who were diagnosed with renal cancer (RCC) of <4 cm by CT scan from January 2005 to December 2013 were collected retrospectively in January 2016 from patient charts and analyzed.STATISTICAL ANALYSIS USED: The cancer-specific survival (CSS) and overall survival (OS) were estimated using Kaplan-Meier methods.RESULTS: The mean age was 62 years (range 40-84 years). Two patients (1.9%) had metastases at the time of diagnosis. Radical nephrectomy was performed in 74 patients (70%); of them, one patients (1.4%) experienced late metastasis (LM). Partial nephrectomy was performed in 30 patients (28%); of them, two patients (6.7%) experienced LM. The mean time to LM was 27 ± 12 months (95% confidence interval: 4-56). CSS rates were 98%, 97%, and 97% for 1, 3, and 5 years, respectively, while OS rates were 96%, 92%, and 86% for 1, 3, and 5 years, respectively. On multivariate analysis, tumor size (P = 0.04), pT3a (P = 0.0017), and patient's age (P = 0.02) at the time of diagnosis were significant predictors of LM.CONCLUSIONS: Even small renal carcinomas may be aggressive, and caution should be taken when offering active surveillance.
U2 - 10.4103/UA.UA_18_17
DO - 10.4103/UA.UA_18_17
M3 - Journal article
C2 - 28794588
VL - 9
SP - 234
EP - 238
JO - Urology Annals
JF - Urology Annals
SN - 0974-7796
IS - 3
ER -
ID: 195546476